CBS62logoNEW2013_blue_final_header_White wwj950-sm2011b 971-ticket-35smb 35h_CBSSportsRad_Detroit

Neogen Acquires Macleod Pharmaceuticals

View Comments
neogen2
(credit: istock) Technology Report
Read More

LANSING — Neogen Corp. (Nasdaq: NEOG) announced  that it has acquired the stock of Macleod Pharmaceuticals, an animal health company headquartered in Fort Collins, Colo. The family-owned business is the original manufacturer of Uniprim, a popular antibiotic for horses.

Macleod has been involved in veterinary pharmaceutical research, development, and manufacturing since 1989. Uniprim is a prescription-only combination of trimethoprim and sulfadiazine that provides effective antibacterial activity against a wide range of infection in animals. The product is widely distributed throughout the U.S., and is also available throughout Canada through an exclusive distribution agreement with Bio-Agri Mix.

“Uniprim represents an outstanding addition to Neogen’s broad line of professional equine products, and will be distributed through Neogen’s current veterinary distributors to professional equine caregivers who are already familiar with Neogen products,” said James Herbert, Neogen’s CEO. “When Macleod’s owners, Dr. Pay and his wife, decided to sell the business and enjoy retirement activities, we were pleased they contacted Neogen.”

The products are manufactured in an FDA-approved pharmaceutical plant owned by Macleod in Fort Collins. Neogen plans to retain Macleod’s current employees and continue to operate from that location.

“As veterinarians, we have spent most of our career in the development of animal health products, first in the United Kingdom, and then here in the U.S.,” said Dr. Michael Pay, Macleod’s chief executive officer. “We were pleased to see our business transfer into the capable hands of a company with the excellent reputation of Neogen. Neogen is widely known among equine veterinarians throughout the U.S. and Canada.”

The Macleod business will be reported as a part of Neogen’s animal safety group. Macleod’s revenues for its most recent 12 months were approximately $4 million.

Neogen develops and markets products dedicated to food and animal safety. The company’s Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen’s Animal Safety Division is a leader in the development of animal genomics along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care and disinfectants.

More at www.neogen.com.

View Comments
blog comments powered by Disqus
Follow

Get every new post delivered to your Inbox.

Join 1,884 other followers